1. Home
  2. APRE vs DKI Comparison

APRE vs DKI Comparison

Compare APRE & DKI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aprea Therapeutics Inc.

APRE

Aprea Therapeutics Inc.

HOLD

Current Price

$0.94

Market Cap

6.9M

Sector

Health Care

ML Signal

HOLD

DKI

DarkIris Inc. Class A Ordinary Shares

N/A

Current Price

$0.39

Market Cap

6.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
APRE
DKI
Founded
2006
2018
Country
United States
Hong Kong
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9M
6.2M
IPO Year
2019
2025

Fundamental Metrics

Financial Performance
Metric
APRE
DKI
Price
$0.94
$0.39
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
77.2K
129.1K
Earning Date
11-12-2025
02-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
26.19
Revenue
$488,239.00
$10,204,329.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$0.01
Revenue Growth
N/A
100.46
52 Week Low
$0.84
$0.30
52 Week High
$4.65
$15.00

Technical Indicators

Market Signals
Indicator
APRE
DKI
Relative Strength Index (RSI) 41.29 N/A
Support Level $0.91 N/A
Resistance Level $1.02 N/A
Average True Range (ATR) 0.05 0.00
MACD 0.01 0.00
Stochastic Oscillator 44.44 0.00

Price Performance

Historical Comparison
APRE
DKI

About APRE Aprea Therapeutics Inc.

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About DKI DarkIris Inc. Class A Ordinary Shares

Darkiris Inc is a comprehensive technology enterprise engaged in the development, publishing and operating of mobile digital games via various third-party digital storefronts. Its activities encompass including game design, programming and graphics, as well as distribution and operation of mobile games on various platforms. Its core product offerings are Games Development; develop, market and distribute its self-developed mobile games; and Games Publishing and Operation. It publish and operate its self-developed mobile games and mobile games it license from other game developers.

Share on Social Networks: